Boston Scientific PE Ratio 2006-2020 | BSX

Current and historical p/e ratio for Boston Scientific (BSX) from 2006 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Boston Scientific PE ratio as of July 03, 2020 is 23.28.
Boston Scientific PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-07-02 35.38 11.64
2020-03-31 32.63 $3.04 10.73
2019-12-31 45.22 $3.33 13.58
2019-09-30 40.69 $0.77 52.84
2019-06-30 42.98 $0.99 43.41
2019-03-31 38.38 $1.28 29.98
2018-12-31 35.34 $1.19 29.70
2018-09-30 38.50 $0.47 81.91
2018-06-30 32.70 $0.36 90.83
2018-03-31 27.32 $0.07 390.29
2017-12-31 24.79 $0.07 354.14
2017-09-30 29.17 $0.61 47.82
2017-06-30 27.72 $0.58 47.79
2017-03-31 24.87 $0.32 77.72
2016-12-31 21.63 $0.26 83.19
2016-09-30 23.80 $0.06 396.67
2016-06-30 23.37 $-0.26 0.00
2016-03-31 18.81 $-0.03 0.00
2015-12-31 18.44 $-0.18 0.00
2015-09-30 16.41 $-0.01 0.00
2015-06-30 17.70 $0.17 104.12
2015-03-31 17.75 $0.09 197.22
2014-12-31 13.25 $0.19 69.74
2014-09-30 11.81 $0.21 56.24
2014-06-30 12.77 $0.18 70.94
2014-03-31 13.52 $0.28 48.29
2013-12-31 12.02 $-0.08 0.00
2013-09-30 11.74 $-0.12 0.00
2013-06-30 9.27 $-0.64 0.00
2013-03-31 7.81 $-3.13 0.00
2012-12-31 5.73 $-2.79 0.00
2012-09-30 5.74 $-2.76 0.00
2012-06-30 5.67 $-2.15 0.00
2012-03-31 5.98 $0.34 17.59
2011-12-31 5.34 $0.27 19.78
2011-09-30 5.91 $0.35 16.89
2011-06-30 6.91 $0.38 18.18
2011-03-31 7.19 $0.34 21.15
2010-12-31 7.57 $-0.72 0.00
2010-09-30 6.13 $-1.58 0.00
2010-06-30 5.80 $-1.57 0.00
2010-03-31 7.22 $-1.53 0.00
2009-12-31 9.00 $-0.49 0.00
2009-09-30 10.59 $-1.40 0.00
2009-06-30 10.14 $-1.57 0.00
2009-03-31 7.95 $-1.60 0.00
2008-12-31 7.74 $-1.37 0.00
2008-09-30 12.27 $-0.06 0.00
2008-06-30 12.29 $-0.20 0.00
2008-03-31 12.87 $-0.19 0.00
2007-12-31 11.63 $-0.33 0.00
2007-09-30 13.95 $0.17 82.06
2007-06-30 15.34 $0.40 38.35
2007-03-31 14.54 $-2.89 0.00
2006-12-31 17.18 $-2.57 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $49.509B $10.735B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $163.141B 28.29
Medtronic (MDT) Ireland $124.955B 20.30
Stryker (SYK) United States $68.946B 22.38
Baxter (BAX) United States $44.233B 27.00
Lonza Group Ag (LZAGY) Switzerland $39.871B 0.00
Terumo (TRUMY) Japan $29.963B 38.30
EssilorLuxottica Societe Anonyme (ESLOY) France $28.693B 0.00
ResMed (RMD) United States $27.846B 43.95
Zimmer Biomet Holdings (ZBH) United States $24.894B 15.66
Smith & Nephew SNATS (SNN) United Kingdom $17.257B 0.00
Sunny Optical Technology (SNPTF) China $16.924B 0.00
Bio-Rad Laboratories (BIO) United States $13.589B 61.86
Insulet (PODD) United States $12.687B 1256.94
DiaSorin S.p.A (DSRLF) Italy $10.994B 0.00
Quidel (QDEL) United States $9.535B 74.93
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
Perrigo (PRGO) Ireland $7.523B 13.46
Hill-Rom Holdings (HRC) United States $7.426B 20.93
GN STORE NORD (GNNDY) Denmark $6.972B 0.00
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.771B 0.00
Haemonetics (HAE) United States $4.656B 27.96
Neogen (NEOG) United States $4.108B 69.58
GW Pharmaceuticals (GWPH) United Kingdom $3.892B 0.00
ICU Medical (ICUI) United States $3.890B 28.38
Agios Pharmaceuticals (AGIO) United States $3.836B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.805B 0.00
Envista Holdings (NVST) United States $3.407B 0.00
NuVasive (NUVA) United States $2.925B 23.49
National Vision Holdings (EYE) United States $2.458B 42.53
TG Therapeutics (TGTX) United States $2.213B 0.00
AtriCure (ATRC) United States $1.855B 0.00
MacroGenics (MGNX) United States $1.450B 0.00
Aurora Cannabis (ACB) Canada $1.390B 0.00
NanoString Technologies (NSTG) United States $1.322B 0.00
Aphria (APHA) Canada $1.231B 0.00
Cardiovascular Systems (CSII) United States $1.137B 0.00
Cerus (CERS) United States $1.109B 0.00
Phibro Animal Health (PAHC) United States $1.055B 21.02
Meridian Bioscience (VIVO) United States $1.019B 38.37
PetIQ (PETQ) United States $1.017B 29.37
DFB Healthcare Acquisitions (AHCO) United States $0.924B 153.85
InMode (INMD) Israel $0.897B 18.97
Vapotherm (VAPO) United States $0.881B 0.00
Zynex (ZYXI) United States $0.834B 83.73
Omeros (OMER) United States $0.826B 0.00
Quanterix (QTRX) United States $0.789B 0.00
OraSure Technologies (OSUR) United States $0.746B 150.25
Eagle Pharmaceuticals (EGRX) United States $0.663B 47.51
Surmodics (SRDX) United States $0.585B 70.49
VAREX IMAGING (VREX) United States $0.584B 14.50
Lantheus Holdings (LNTH) United States $0.579B 11.65
LeMaitre Vascular (LMAT) United States $0.532B 30.29
BioLife Solutions (BLFS) United States $0.467B 163.45
Owens & Minor (OMI) United States $0.464B 12.27
Repro-Med Systems (KRMD) United States $0.394B 302.33
Viemed Healthcare (VMD) United States $0.367B 32.55
Cytosorbents (CTSO) United States $0.361B 0.00
Utah Medical Products (UTMD) United States $0.315B 22.85
HEXO (HEXO) $0.311B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.304B 0.00
Organigram Holdings (OGI) Canada $0.285B 0.00
Female Health (VERU) United States $0.229B 0.00
Chimerix (CMRX) United States $0.196B 0.00
Bovie Medical (APYX) United States $0.185B 0.00
Evolus (EOLS) United States $0.185B 0.00
Surface Oncology (SURF) United States $0.178B 0.00
Exagen (XGN) United States $0.161B 0.00
Fonar (FONR) United States $0.135B 11.94
Rockwell Medical (RMTI) United States $0.133B 0.00
United Health Products (UEEC) United States $0.131B 0.00
Liberty Health Sciences (LHSIF) Canada $0.120B 0.00
Wound Management Technologies (SMTI) United States $0.112B 0.00
MTech Acquisition (KERN) United States $0.109B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.084B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.082B 0.00
Nephros (NEPH) United States $0.073B 0.00
United-Guardian (UG) United States $0.071B 16.51
Capricor Therapeutics (CAPR) United States $0.065B 0.00
Brainsway (BWAY) Israel $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.055B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.012B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00